首页|miR-143-5p和miR-335-5p在宫颈癌组织中的表达及临床意义

miR-143-5p和miR-335-5p在宫颈癌组织中的表达及临床意义

Expression and clinical significance of miR-143-5p and miR-335-5p in cervical cancer tissues

扫码查看
目的 分析微小核糖核酸-143-5p(miR-143-5p)和miR-335-5p在宫颈癌组织中的表达及其临床意义.方法 选择2018年7月-2020年6月康复大学青岛中心医院/青岛市中心医院肿瘤妇科二科手术治疗的宫颈癌患者120例,随访期间失访5例,根据随访结果将患者分为预后良好组78例和预后不良组37例;采用实时荧光定量PCR(RT-qPCR)法检测宫颈癌组织及其癌旁组织中miR-143-5p、miR-335-5p的相对表达量;多因素Logistic回归分析影响宫颈癌患者预后的因素;受试者工作特征(ROC)曲线分析miR-143-5p、miR-335-5p预测宫颈癌患者预后的价值.结果 癌组织中 miR-143-5p、miR-335-5p 水平低于癌旁组织(t/P=22.710/<0.001、22.950/<0.001);FIGO 分期为Ⅲ~Ⅳ期、肿瘤中低分化、有淋巴结转移的宫颈癌患者癌组织中miR-143-5p、miR-335-5p水平低于FIGO分期为Ⅰ~Ⅱ 期、肿瘤高分化、无淋巴结转移的患者(miR-143-5p:x2/P=3.041/0.003、3.573/0.001、3.443/0.001;miR-335-5p:x2/P=5.769/<0.001、2.890/0.005、2.738/0.007);预后不良组癌组织 miR-143-5p、miR-335-5p 水平低于预后良好组(t/P=3.718/<0.001、3.150/0.002);预后良好组患者FIGO分期Ⅰ~Ⅱ期、无淋巴结转移比例高于预后不良组(x2/P=18.261/<0.001、9.635/0.002);FIGO分期Ⅲ~Ⅳ期是影响宫颈癌患者预后的危险因素[OR(95%CI)=4.105(1.484~11.353)],而 miR-143-5p 高、miR-335-5p 高是其保护因素[OR(95%CI)=0.196(0.084~0.458)、0.220(0.088~0.549)];癌组织miR-143-5p、miR-335-5p及二者联合预测宫颈癌患者预后的AUC分别为0.743、0.726、0.879,二者联合优于各自单独预测价值(Z/P=2.346/0.019、2.601/0.009).结论 miR-143-5p、miR-335-5p在宫颈癌组织中呈下调表达,二者联合预测宫颈癌患者预后的价值较高.
Objective To analyze the expression and clinical significance of microribonucleic acid-143-5p(miR-143-5p)and microribonucleic acid-335-5p(miR-335-5p)in cervical cancer tissues.Methods From July 2018 to June 2020,120 cervical cancer patients treated in our hospital were collected.Due to 5 cases of lost follow-up,a total of 115 cases were in-cluded in the statistical calculation;real-time fluorescence quantitative PCR(RT-qPCR)method was applied to detect the rel-ative expression levels of miR-143-5p and miR-335-5p in cervical cancer tissue and its adjacent tissues;multivariate Logistic regression was applied to analyze the factors affecting the prognosis of cervical cancer patients;receiver operating charac-teristic(ROC)curve was applied to analyze the value of miR-143-5p combined miR-335-5p in predicting the prognosis of cer-vical cancer patients.Results The levels of miR-143-5p and miR-335-5p in cancer tissues were obviously lower than those in adjacent tissues(t/P=22.710/<0.001,22.950/<0.001);the levels of miR-143-5p and miR-335-5p in cervical cancer tissues of patients with FIGO staging of stages Ⅲ-Ⅳ,poorly differentiated tumors,and lymph node metastasis were obviously lower than those of patients with FIGO staging of stages Ⅰ-Ⅱ,highly differentiated tumors,and no lymph node metasta-sis(miR-143-5p:x2/P=3.041/0.003,3.573/0.001,3.443/0.001;miR-335-5p:x2/P=5.769/<0.001,2.890/0.005,2.738/0.007);the lev-els of miR-143-5p and miR-335-5p in cancer tissues of the poor prognosis group were obviously lower than those of the good prognosis group(t/P=3.718/<0.001,3.150/0.002);the proportion of patients with FIGO stage Ⅰ-Ⅱ and no lymph node metastasis in the good prognosis group was higher than that in the poor prognosis group(x2/P=18.261/<0.001,9.635/0.002);FIGO stage Ⅲ-Ⅳ was risk factor for cervical cancer patients[OR(95%CI)=4.105(1.484-11.353)],while high levels of miR-143-5p and miR-335-5p were protetive factors[OR(95%CI)=0.196(0.084-0.458),0.220(0.088-0.549)];the AUC of serum miR-143-5p,miR-335-5p and their combination in predicting the prognosis of patients with cervical cancer were 0.743,0.726 and 0.879,respectively,and the combination of the two was better than their single prediction value(Z/P=2.346/0.019,2.601/0.009).Conclusion MiR-143-5p and miR-335-5p are downregulated in cervical cancer tissue,and the com-bination of the two has a high value in predicting the prognosis of cervical cancer patients.

Cervical cancerMicroribonucleic acid-143-5pMicroribonucleic acid-335-5pPrognosis

陈菁、刘岩、姜文静、刘羽、杨晨曦

展开 >

266042 山东青岛,康复大学青岛中心医院/青岛市中心医院肿瘤妇科二科

266034 山东青岛,青岛市妇女儿童医院产科

266034 山东青岛,青岛市妇女儿童医院生殖医学中心

宫颈癌 微小核糖核酸-143-5p 微小核糖核酸-335-5p 预后

山东省科技创新计划入选项目(2023)山东省医药卫生科技发展计划

SFYXH-2023W025202205020092

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(6)